x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:09:01

BIO International 2025: Oppenheimer's Head of...

BiotechTV - News ·

2025/06/17

He describes how sentiment and the M&A environment have been improving, as well as some areas of the financing market. However, he cautions that it is very difficult to get early-stage development funded and that companies need to be creative to get phase 1 studies done.

en-us

00:10:02

BIO International 2025: Perspective Therapeutics CEO...

BiotechTV - News ·

2025/06/17

He describes why he likes the strong and quick elements of alpha-particles, and how Perspective's have been designed to have a short half-life. Plus, background on programs targeting MC1R, SSTR2, and FAP-α.

en-us

00:09:21

BIO International 2025: CEO Paul Hastings discusses...

BiotechTV - News ·

2025/06/17

He describes why he believes NK cells are better suited thank T-cells for autoimmune, and updates us on the company's clinical programs. Nkarta will share a data on everything before the end of the year.

en-us

00:08:02

BIO International 2025: Germany's Aicuris, a company...

BiotechTV - News ·

2025/06/17

CEO Larry Edwards describes the unmet need in the immunocompromised space, and highlights Aicuris' commercial CMV product (PREVYMIS), partnered with Merck/MSD, and R&D products targeting HSV and BKV.

en-us

00:11:58

BIO International 2025: UroGen CEO Liz Barrett...

BiotechTV - News ·

2025/06/17

She describes the unmet need for a new therapy in this setting, and compares and contrasts ZUSDURI to going through multiple transurethral resection of bladder tumor (TURBT) surgeries. Plus, the potential addressable market, and what she believes the approval means for UroGen as a company.

en-us

00:06:37

BIO International 2025: eGenesis CEO Mike Curtis...

BiotechTV - News ·

2025/06/17

He describes the successful transplant of Tim Andrews, who threw out the first pitch at a Red Socks game last week, and discusses what is next for this program. Plus, the status of liver and heart programs.

en-us

00:14:04

BIO International 2025: Stifel's Tim Opler comments...

BiotechTV - News ·

2025/06/16

He explains how M&A and fundraising have been improving, and he describes what types of companies have been most appealing to investors. Plus, his take on the potential most favored nation policy, companies with negative enterprise values, and China competition.

en-us

00:14:02

BIO International 2025: Ocugen CEO Shankar Musunuri...

BiotechTV - News ·

2025/06/16

He discusses the company's gene therapy approach to retinitis pigmentosa, Stargardt disease (which just had a pivotal cleared by FDA today), and geographic atrophy.

en-us

00:16:03

EHA 2025: Arcellx CEO Rami Elghandour discusses the...

BiotechTV - News ·

2025/06/14

He goes over the results, and compares and contrasts the therapy's profile to the primary competitor that is currently on the market, Carvykti. Plus learnings from year two of a physician survey, and his current take on CAR-T for autoimmune and CD123 for AML.

en-us

00:18:21

EHA 2025: The CEO of Ascentage Pharma, which had its...

BiotechTV - News ·

2025/06/14

Dajun Yang shares the history of Ascentage, talks about what makes the BCR-ABL program, which Takeda took an option on, a third-generation TKI, and highiglights Bcl-2 and EED.

en-us

00:13:09

EHA 2025: MaaT Pharma presented an update for its...

BiotechTV - News ·

2025/06/14

CMO Gianfranco Pittari walks us through data from the pivotal ARES study that MaaT announced in January and filed with the EMA. Plus, an EHA presentation from an early access program that is a follow-up from data we saw in ASH in December.

en-us

00:15:17

Microsoft's Chief Scientific Officer for Health and...

BiotechTV - News ·

2025/06/13

Matthew Lungren describes his belief how AI will "save time before it saves lives," and discusses how the clinical workforce is getting more used to adopting it. Plus how AI might affect cancer care and drug development R&D.

en-us

00:16:26

EHA 2025: CEO Arthur Sands discusses Nurix...

BiotechTV - News ·

2025/06/13

He discusses the P1 data presented at EHA for CLL and WM, which he says showed efficacy across mutations, durability, and clean safety. Plus, recent #AACR25 data on BTK, BRAF and Aurora A, and his toughts on STAT6, IRAK4, and other autoimmune targets.

en-us

00:15:13

EHA 2025: CEO Jonathan Dickinson discusses Innate...

BiotechTV - News ·

2025/06/13

He describes Innate's NK cell platform and covers programs targeting CD20, CD123, BCMA, and B7-H3. Plus Lacutamab data, updates on the company's Nectin-4 ADC, and Monalizumab.

en-us

00:08:42

CLAIRITY BREAST, an AI platform that predicts...

BiotechTV - News ·

2025/06/12

CEO Leff Luber describes the tool, which is mean to augment a radiologist's analysis, and how its modeling algorithm takes into account pixels that may be unseen by the human eye.

en-us

00:09:23

Nucleate UK held its "The Forum" event in London -...

BiotechTV - News ·

2025/06/09

BiotechTV attended the event, and recorded comments from the Nucleate team, who describe the scale and role of Nucleate in this area. We hear about the Activator program, and meet entrepreneurs who have benefitted from it. Plus, how Nucleate has partnered with the government's Advanced Research and Invention Agency (ARIA) in the UK.

en-us

00:10:08

AI News: Artera presented data at #ASCO25 showing...

BiotechTV - News ·

2025/06/06

CMO Tim Showalter describes the finding, which was selected as a "Best of ASCO" oral presentation. Plus, helping to determine how certain patients and ethnic groups will respond to therapies in the real world. and what is next for Artera.

en-us

00:11:26

Kymera Therapeutics' Founder & CEO Nello Mainolfi...

BiotechTV - News ·

2025/06/04

He describes the data, which was released on Monday, and highlights the future of the program - including how we will see more data in atopic dermatitis patients by the end of the year. Plus, discussing a new target Kymera recently announced for other immuno-inflammatory diseases, IRF5.

en-us

00:11:40

ASCO 2025: PharmaMar presented data showing that the...

BiotechTV - News ·

2025/06/03

Global Product Lead José Antonio López-Vilariño describes the data and VP of Strategic Development Pascal Besman puts the result in context of this cancer type and stage that historically has had a very poor prognosis.

en-us

00:14:28

ASCO 2025: France based Transgene presented data for...

BiotechTV - News ·

2025/06/03

Chairman and CEO Alessandro Riva describes the computational work that is done to choose the personalized neoantigens for this cancer vaccine, and he describes why head and neck was a good fit to test the therapy out in. Plus, he covers the data and talks about next steps.

en-us

362 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter